Frohlich Mark W 4
4 · RIGEL PHARMACEUTICALS INC · Filed May 28, 2025
Insider Transaction Report
Form 4
Frohlich Mark W
Director
Transactions
- Award
Common Stock
2025-05-23+1,250→ 1,250 total - Award
Stock Option (Right to Buy)
2025-05-23+1,500→ 1,500 totalExercise: $18.95Exp: 2035-05-23→ Common Stock (1,500 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
- [F2]The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.